CRTC3
CRTC3 (CREB regulated transcription coactivator 3, also known as FLJ21868) is a member of the TORC family of transcriptional coactivators. It enhances CREB1-dependent transcription at cAMP response element sites and has been linked to mitochondrial biogenesis. Browse Assay Genie's current range of CRTC3 research reagents below, or read on for the biology behind the target.
CRTC3 is a transcriptional coactivator for CREB1. It activates transcription through both consensus and variant cAMP response element (CRE) sites, and it enhances the interaction of CREB1 with TAF4. It acts in the SIK/TORC signalling pathway and is active when dephosphorylated. Its activity does not depend on phosphorylation of CREB1 at Ser-133. CRTC3 regulates the expression of specific CREB-activated genes, including the steroidogenic gene StAR. It is also a potent coactivator of PPARGC1A and an inducer of mitochondrial biogenesis in muscle cells. In addition, it acts as a coactivator for TAX-driven activation of the human T-cell leukaemia virus type 1 (HTLV-1) long terminal repeats.
The CRTC3 gene belongs to the CREB regulated transcription coactivator family, also called the TORC family. Members of this family regulate CREB-dependent gene transcription in a phosphorylation-independent manner and may be selective for cAMP-responsive genes. The CRTC3 protein is found in both the nucleus and the cytoplasm. The mouse ortholog is Crtc3. Researchers working with the CRTC3 protein often study it alongside related family members such as CRTC2.
NCBI Gene notes that CRTC3 may induce mitochondrial biogenesis and attenuate catecholamine signalling in adipose tissue. A translocation between this gene and the Notch coactivator gene mastermind-like 2 produces a fusion protein that has been reported in mucoepidermoid carcinomas. Alternative splicing gives multiple transcript variants that encode different protein isoforms.
CRTC3 coactivates CREB1 at consensus and variant CRE sites, making it a useful target for studying cAMP-responsive transcription.
CRTC3 is a potent coactivator of PPARGC1A and an inducer of mitochondrial biogenesis in muscle cells.
The protein may attenuate catecholamine signalling in adipose tissue, which links it to studies of adipocyte regulation.
A CRTC3-MAML2 fusion is reported in mucoepidermoid carcinoma, and CRTC3 acts as a coactivator for HTLV-1 TAX.
CRTC3 is a transcriptional coactivator for CREB1. It activates transcription at consensus and variant CRE sites, enhances the CREB1–TAF4 interaction and regulates CREB-activated genes such as StAR. It is active when dephosphorylated within the SIK/TORC signalling pathway.
CRTC3 is also listed as FLJ21868, and its full name is CREB regulated transcription coactivator 3. It belongs to the TORC family. Alternative splicing produces multiple transcript variants that encode different protein isoforms.
A translocation between CRTC3 and the Notch coactivator gene mastermind-like 2 creates a fusion protein reported in mucoepidermoid carcinomas. The mouse ortholog is Crtc3; check the datasheet of any product for its validated reactivity.
Other TORC family coactivators and CREB pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q6UUV7; product specifications from Assay Genie datasheets.